Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis

J Antimicrob Chemother. 1997 Dec;40(6):899-902. doi: 10.1093/jac/40.6.899.

Abstract

In order to establish whether long-term itraconazole therapy can affect adrenal or testicular function, the adrenal response to corticotrophin and testosterone was evaluated by radioimmunoassay in 15 patients undergoing treatment for chromoblastomycosis. Mean cortisol and testosterone concentrations were 12.4 microg/dL and 454 ng/dL respectively at baseline and 15.4 microg/dL and 480 ng/dL respectively after 12.4+/-5.2 months of treatment with itraconazole (200-400 mg daily). Results were analysed using Student's t-test. There was no clinical or laboratory evidence of steroidogenic or androgenic impairment.

Publication types

  • Comparative Study

MeSH terms

  • Adrenal Glands / drug effects*
  • Adrenal Glands / metabolism
  • Adrenocorticotropic Hormone / pharmacology
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents / therapeutic use*
  • Chromoblastomycosis / drug therapy*
  • Female
  • Humans
  • Hydrocortisone / blood
  • Itraconazole / therapeutic use*
  • Male
  • Middle Aged
  • Testis / drug effects*
  • Testis / metabolism
  • Testosterone / blood

Substances

  • Antifungal Agents
  • Itraconazole
  • Testosterone
  • Adrenocorticotropic Hormone
  • Hydrocortisone